Abstract
Objective Acute respiratory distress syndrome (ARDS) associated with high mortality is the common complication in acute pancreatitis(AP). The aim of this study was to formulate and validate an individualized predictive nomogram for in-hospital incidence of ARDS in AP patients.
Method From January 2017 to December 2018, 779 individuals with AP were included in this study. They were randomly distributed into primary cohort (n=560) and validation cohort (n=219). Based on the primary cohort, risk factors were identified by logistic regression model and a nomogram was performed. The nomogram was validated in the primary and validation cohort by the bootstrap validation method. The calibration curve was applied to evaluate the consistency between nomogram and ideal observation.
Results There were 728 patients in the non-ARDS group and 51 in the ARDS group, with an incidence rate of about 6.55%. Five independent factors including white blood counts(WBC), prothrombin time(PT), albumin(ALB), serum creatinine(SCR) and triglyceride (TG) were associated with in-hospital incidence of ARDS in AP patients. A nomogram was constructed based on the five independent factors with primary cohort of AUC 0.821 and validation cohort of AUC 0.822. Calibration curve analysis indicated that the predicted probability was in accordance with the observed probability in both primary and validation cohorts.
Conclusions The study developed an intuitive nomogram with easily available laboratory parameters for the prediction of in-hospital incidence of ARDS in patients with AP. The incidence of ARDS for an individual patient can be fast and conveniently evaluated by our nomogram.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This manuscript was supported by the Sanitation and Health Committee Foundation of Hunan Province, China (20200075).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
List of abbreviations
- ARDS
- acute respiratory distress syndrome
- AP
- acute pancreatitis
- SAP
- severe acute pancreatitis
- ICU
- Intensive care unit
- LOS
- length of stay
- SBP
- systolic blood pressure
- DBP
- diastolic blood pressure
- HR
- heart rate
- RR
- respiratory rate
- SaO2
- oxyhemoglobin saturation
- WBC
- white blood cell count
- N
- neutrophil
- L
- lymphocyte
- HCT
- hematocrit
- PLT
- platelet
- FBS
- fasting blood sugar
- PT
- prothrombin time
- APTT
- activated partial thromboplastin time
- ALB
- albumin
- ALT
- alanine aminotransferase
- BUN
- blood urea nitrogen
- SCR
- serum creatinine
- AMS
- amylase
- LPS
- lipase
- LDH
- lactate dehydrogenase
- HDL
- high density lipoprotein
- LDL
- low density lipoprotein
- TG
- triglyceride
- SOFA
- sequential organ failure assessment
- BISAP
- bedside index of severity in acute pancreatitis
- SIRS
- systemic inflammatory response syndrome,
- AUC
- area under receiver operating characteristic curve
- OR
- odds ratio
- AKI
- acute kidney injury
- FFA
- free fatty acid
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.